Trial Profile
Open label, single-dose, randomized, 2-period, 2-sequence crossover bioequivalence study of pregabalin in healthy Korean male subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 23 Jan 2017
Price :
$35
*
At a glance
- Drugs Pregabalin (Primary)
- Indications Fibromyalgia; Generalised anxiety disorder; Generalised epilepsy; Neuropathic pain; Pain; Partial epilepsies; Postherpetic neuralgia; Postoperative pain; Restless legs syndrome
- Focus Pharmacokinetics
- 23 Jan 2017 New trial record
- 27 Dec 2016 Results published in the International Journal of Clinical Pharmacology and Therapeutics
- 27 Dec 2016 According to the results published in the International Journal of Clinical Pharmacology and Therapeutics, this study was conducted at the Clinical Trials Center of Kyung Hee University Hospital.